Sipai Health Technology (314.HK) - Valuation Has Collapsed, but a Reversal Is Not yet in Sight
Sipai’s performance would be hard to improve due to problematic business model. Even as valuation has plummeted, it's still difficult for investors...
Sipai Health Tech: Market Overreacts to a Mediocre Business
Sipai's shares have rallied more than 35% since its IPO. Largest biz segment commands very lower GPM and high-margin insurance biz's contribution...
Sipai Health Technology (314.HK) - Unjustified Valuation and Problematic Business Model
The sustainability/stability of Sipai’s performance/growth potential is worrying. Weak profitability make Sipai hard to be breakeven.High valuation...
HSCI Index Rebalance: 35 Adds, 28 Deletes & Changes to Southbound Stock Connect
There are 35 adds & 28 deletes for the HSCI in March leading to 29 adds & 20 deletes for Stock Connect. 19 index constituents could be dropped from...
No more insights